Compare TSLX & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TSLX | LKFT |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2011 | 2007 |
| Metric | TSLX | LKFT |
|---|---|---|
| Price | $17.58 | $34.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 6 |
| Target Price | $19.52 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 504.9K | 241.5K |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | ★ 10.08% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.15 | N/A |
| P/E Ratio | $34.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.04 | $25.68 |
| 52 Week High | $22.84 | $35.54 |
| Indicator | TSLX | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 71.24 |
| Support Level | $17.17 | $28.50 |
| Resistance Level | $17.94 | N/A |
| Average True Range (ATR) | 0.42 | 0.86 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 44.14 | 63.72 |
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.